← All candidates
7 insider filings on record.
7 filings on record.
CLBTCellebrite DI Ltd.
NasdaqGS · Technology · $2.89B
$11.25
-3.60% · Sep 15
7 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 6 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$2.89B
Float
112.5M
45% public
Short % float
Pro
Price / profit
50.0
Price / future profit
17.6
Price / sales
5.6
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
2 more transactions on Pro →Context
Wall St
$21.00 avg target
+86.7% vs today · 7 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26$0.12 act+$0.02
Q4 '25$0.14 act+$0.00
Q3 '25$0.14 act+$0.01
Q2 '25$0.12 act+$0.01
Coverage
Cellebrite (CLBT)’s Total Addressable Market Is Large, Growing, And Likely Understated, According To DA DavidsonInsider Monkey · 06-20Is Cellebrite DI Ltd. (CLBT) A Good Stock To Buy Now?Insider Monkey · 06-19Tracking How the Cellebrite (CLBT) Investment Narrative Is Evolving Without New Analyst TargetsSimply Wall St. · 06-04Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows
The file stays open
7 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice